En esta página
01INO precio
02Instantánea
03Gráfico
04Divisiones de acciones
05Acerca de
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
INO Inovio Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 12, 2026
$1,16
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$0,56mínimo 52 semanas
$2,68máximo 52 semanas
Capitalización Bursátil (MRQ)
$96M
P/E (TTM)
-1.1
BPA (TTM)
$-1.04
Ingresos (TTM)
$0
tus insignias
Rango 52S
$1–$3
Calificación del Analista
BUY
Precio Objetivo
$3
P/E
-1.1
ROE
-409.9%
Margen de Beneficio Neto
-130000.0%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
INO Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.16
Capitalización Bursátil (MRQ)
$96M
P/E (TTM)
-1.1
BPA (TTM)
$-1.04
Ingresos (TTM)
$0
ROE (TTM)
-409.9%
Rango 52S
$1–$3
INO Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 25 de enero de 2024 | 1-for-12 | Inversa |
| 6 de junio de 2014 | 1-for-4 | Inversa |
| 13 de septiembre de 2004 | 1-for-4 | Inversa |
Acerca de Inovio Pharmaceuticals, Inc. - Common Stock Descripción general de la empresa de Wikipedia
Inovio Pharmaceuticals es una compañía estadounidense de biotecnología centrada en el descubrimiento, desarrollo y comercialización de productos de ADN sintético para el tratamiento de cánceres y enfermedades infecciosas. En abril de 2020, Inovio se encontraba entre unas 100 empresas, centros académicos u organizaciones de investigación que desarrollaban una vacuna candidata para el tratamiento de personas infectadas con el coronavirus COVID-19, con 115 candidatos vacunales en desarrollo.
### Ensayos clínicos
El 11 de octubre/2021, el presidente de Colombía Iván Duque, manifestó: “Nos reunimos con Joseph Kim, CEO de Inovio Pharmaceuticals, farmacéutica que el INVIMA autorizó para realizar ensayo clínico de la fase 3 de vacunas contra Covid en Colombia. Exploramos la firma de memorando de entendimiento para desarrollo y producción de biológicos en el país”, autorizando la entrada para poder culminar sus estudios acerca de su biológico.
== Referencias ==
Fuente: Wikipedia, CC BY-SA 4.0 · Ver en Wikipedia ↗
sectorHealthcare
industriaBiotechnology
empleados112
paísUS
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$65.3K2016-12-31 → 2025-12-31
BPA$-1.812016-12-31 → 2025-12-31
Flujo de caja libre$-89M2016-12-31 → 2025-12-31
Margen neto-130000.0%2016-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | INO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -1.1promedio 5A ≈-1.4 | ≈-1.4 | · | · | |
| P/S | 1224.9promedio 5A ≈2020.9 | ≈2020.9 | 232.7 | Sobrevalorado | |
| P/C (MRQ) | 21.9promedio 5A ≈12.2 | ≈12.2 | 2.8 | Sobrevalorado | |
| Precio / FCF (TTM) | -1.2promedio 5A ≈-17.0 | ≈-17.0 | · | · | |
| Precio / Flujo de Caja (TTM) | -1.2promedio 5A ≈-17.1 | ≈-17.1 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 3.3promedio 5A ≈12.7 | ≈12.7 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | INO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Operating Margin (Margen Operativo) | -132871.3%promedio 5A ≈-44273.6% | ≈-44273.6% | -1300.3% | Débil | |
| EBITDA Margin (Margen EBITDA) | -132871.3%promedio 5A ≈-44273.6% | ≈-44273.6% | -1300.3% | Débil | |
| Pretax Margin (Margen antes de impuestos) | -130000.0%promedio 5A ≈-43057.0% | ≈-43057.0% | -2475.3% | Débil | |
| Net Profit Margin (Margen de Beneficio Neto) | -130000.0%promedio 5A ≈-43066.1% | ≈-43066.1% | -2227.9% | Débil | |
| ROA (TTM) | -114.6%promedio 5A ≈-68.6% | ≈-68.6% | -45.0% | Débil | |
| ROE (TTM) | -409.9%promedio 5A ≈-153.0% | ≈-153.0% | -103.7% | Débil | |
| ROIC | -360.3%promedio 5A ≈-168.6% | ≈-168.6% | -93.3% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | INO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 1.0promedio 5A ≈3.6 | ≈3.6 | 5.0 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 1.3promedio 5A ≈3.3 | ≈3.3 | 3.3 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | INO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -70.0%promedio 5A ≈33.3% | ≈33.3% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | -81.5%promedio 5A ≈-61.2% | ≈-61.2% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | -61.2% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | INO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.0 | ≈0.0 | 0.0 | Débil | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 0.1promedio 5A ≈0.8 | ≈0.8 | 5.9 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$583.42 | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
24.6%
Próximo informe
Nov 09, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 10, 2026 | $-0.07 | $-0.22 | 68.0% |
| 31 de marzo de 2026 | May 11, 2026 | $-0.28 | $-0.35 | 20.8% |
| 31 de diciembre de 2025 | $0.06 | $-0.36 | 116.6% | |
| 30 de septiembre de 2025 | $-0.87 | $-0.43 | -103.6% | |
| 30 de junio de 2025 | $-0.61 | $-0.62 | 0.86% | |
| 31 de marzo de 2025 | $-0.41 | $-0.75 | 45.0% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65.3K | $217.8K | $832.0K | $10M | $2M | $7M | $4M | $30M | $42M | $35M | $41M | $10M | |
| R&D Expense | $54M | $76M | $87M | $188M | $249M | $94M | $88M | $95M | $99M | $89M | $58M | $34M | |
| SG&A Expense | $33M | $37M | $48M | $90M | $54M | $37M | $27M | $29M | $28M | $24M | $18M | $16M | |
| Operating Expenses | $87M | $113M | $145M | $278M | $303M | $131M | $115M | $125M | $126M | $112M | $75M | $50M | |
| Operating Income | $-87M | $-112M | $-144M | $-268M | $-301M | $-124M | $-111M | $-94M | $-84M | $-76M | $-34M | $-39M | |
| Interest Expense | · | · | $1M | $1M | $2M | $9M | $8M | $0 | $25.9K | · | · | · | |
| Interest Income | $2M | $5M | $8M | $5M | $3M | $3M | $3M | $2M | $2M | · | · | · | |
| Other Non-op | $-3M | $-3M | $-5M | $-4M | $343.4K | $-704.9K | $496.2K | $-1M | $-197.5K | · | · | · | |
| Pretax Income | $-85M | $-107M | $-135M | $-278M | $-303M | $-163M | $-121M | $-95M | $-88M | $-74M | $-31M | $-36M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-257.3K | $2M | $0 | $0 | $-2M | $0 | |
| Net Income | $-85M | $-107M | $-135M | $-280M | $-304M | $-166M | $-119M | $-97M | $-88M | $-74M | $-29M | $-36M | |
| EPS (Basic) | $-1.81 | $-3.95 | $-6.09 | $-14.07 | $-17.45 | $-1.07 | $-1.21 | $-1.05 | $-1.08 | $-1.01 | $-0.43 | $-0.61 | |
| EPS (Diluted) | $-1.81 | $-3.95 | $-6.09 | $-14.07 | $-17.45 | $-1.07 | $-1.21 | $-1.05 | $-1.09 | $-1.01 | $-0.44 | $-0.64 | |
| Shares (Basic) | 46,886,413 | 27,160,863 | 22,173,662 | 19,885,182 | 17,402,483 | 155,126,857 | 98,717,999 | 92,539,997 | 81,777,493 | 73,214,766 | 68,198,142 | 59,127,349 | |
| Shares (Diluted) | 46,886,413 | 27,160,863 | 22,173,662 | 19,885,182 | 17,402,483 | 155,126,857 | 98,717,999 | 92,539,997 | 81,918,022 | 73,214,766 | 68,365,265 | 59,408,252 | |
| EBITDA | $-87M | $-112M | $-144M | $-268M | $-301M | $-124M | $-111M | $-94M | $-84M | $-76M | $-34M | $-39M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $44M | $66M | $14M | $46M | $71M | $251M | $22M | $24M | $24M | $19M | $58M | $41M | |
| Short-term Investments | $14M | $28M | $131M | $207M | $330M | $161M | $67M | $58M | $104M | $86M | $105M | $53M | |
| Receivables | $450 | $1M | $2M | $2M | $5M | $19M | $700.1K | $3M | $6M | $16M | $7M | $3M | |
| Prepaid Expense | $3M | $4M | $5M | $50M | $39M | $40M | $2M | $1M | $3M | $2M | $917.3K | $798.0K | |
| Current Assets | $61M | $98M | $153M | $315M | $448M | $471M | $94M | $88M | $138M | $125M | $172M | $99M | |
| PP&E (Net) | $3M | $4M | $5M | $8M | $17M | $11M | $13M | $16M | $18M | $9M | $7M | $5M | |
| PP&E (Gross) | $20M | $20M | $26M | $29M | $36M | $27M | $26M | $26M | $25M | $14M | $11M | $7M | |
| Accum. Depreciation | $17M | $16M | $21M | $22M | $19M | $16M | $13M | $10M | $7M | $5M | $4M | $3M | |
| Goodwill | · | · | $0 | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $10M | $10M | |
| Intangibles | · | · | $0 | $2M | $3M | $3M | $4M | $5M | $6M | $8M | $4M | $5M | |
| Other Non-current Assets | $2M | $2M | $605.3K | $684.0K | $1M | $26M | $3M | $3M | $3M | $2M | $670.8K | $474.6K | |
| Total Assets | $74M | $113M | $171M | $349M | $496M | $540M | $144M | $131M | $187M | $174M | $214M | $132M | |
| Accounts Payable | · | · | · | $80M | $48M | $21M | $18M | $23M | $23M | $20M | $13M | $6M | |
| Accrued Liabilities | · | · | · | · | · | · | · | $6M | $9M | $6M | $3M | $2M | |
| Current Liabilities | $44M | $35M | $43M | $97M | $66M | $42M | $32M | $35M | $35M | $44M | $31M | $14M | |
| Capital Leases | $7M | $9M | $11M | $13M | $15M | $18M | $20M | · | · | · | · | · | |
| Deferred Tax | · | · | $0 | $32.0K | $32.0K | $32.0K | $32.0K | $24.8K | $24.8K | $174.8K | $175.6K | $504.0K | |
| Other Non-current Liabilities | · | · | · | $0 | $14.8K | $57.7K | $36.9K | $87.3K | $0 | · | · | · | |
| Total Liabilities | $50M | $45M | $54M | $126M | $96M | $79M | $139M | $44M | $45M | $50M | $38M | $20M | |
| Long-term Debt | · | · | · | · | · | · | · | $0 | · | · | · | · | |
| Common Stock | $69.0K | $36.1K | $22.8K | $21.1K | $217.4K | $186.9K | $101.4K | $97.2K | $90.4K | $74.1K | $72.2K | $60.7K | |
| Paid-in Capital | $1.84B | $1.80B | $1.74B | $1.71B | $1.61B | $1.37B | $743M | $708M | $666M | $557M | $534M | $443M | |
| Retained Earnings | $-1.82B | $-1.73B | $-1.62B | $-1.49B | $-1.21B | $-906M | $-740M | $-620M | $-523M | $-435M | $-361M | $-332M | |
| AOCI | $-638.0K | $-675.7K | $-662.6K | $-698.7K | $-282.2K | $-256.1K | $472.6K | $-528.9K | $-117.0K | $1M | $3M | $-251.4K | |
| Stockholders' Equity | $24M | $69M | $117M | $222M | $400M | $461M | $3M | $87M | $142M | $123M | $176M | $111M | |
| Liabilities + Equity | $74M | $113M | $171M | $349M | $496M | $540M | $144M | $131M | $187M | $174M | $214M | $132M | |
| Shares Outstanding | 68,996,647 | 36,099,991 | 22,793,075 | 21,090,938 | 217,382,887 | 186,851,493 | 101,361,034 | 97,225,810 | 90,357,644 | 74,062,370 | 72,217,965 | 60,741,082 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $7M | $11M | $23M | $26M | $16M | $11M | $11M | $13M | $10M | $6M | $5M | |
| Deferred Tax | · | $0 | $-32.0K | $0 | $0 | $0 | $-263.0K | $0 | $0 | $0 | $-2M | $27.0K | |
| Amort. of Intangibles | · | $0 | $145.4K | $496.5K | $520.4K | $547.1K | $1M | $1M | $2M | $1M | $870.2K | $942.7K | |
| Operating Cash Flow | $-89M | $-104M | $-124M | $-216M | $-216M | $-178M | $-98M | $-74M | $-63M | $-63M | $-12M | $-30M | |
| CapEx | $285.7K | $487.8K | $320.9K | $969.2K | $1M | $2M | $987.9K | $2M | $10M | $3M | $3M | $1M | |
| Investing Cash Flow | $14M | $104M | $87M | $110M | $-175M | $-59M | $-9M | $42M | $-28M | $16M | $-55M | $-36M | |
| Debt Issued | · | · | · | · | $0 | $0 | $97M | $0 | $0 | · | · | · | |
| Net Debt Issued | · | · | · | · | $0 | $0 | $97M | · | · | · | · | · | |
| Stock Issued | $35M | $36M | $5M | $83M | $209M | $454M | $9M | $29M | $94M | $6M | $82M | $59M | |
| Net Stock Activity | $35M | $36M | $5M | $83M | $209M | $454M | $9M | $29M | $94M | $6M | $82M | $59M | |
| Financing Cash Flow | $53M | $51M | $5M | $82M | $211M | $465M | $105M | $31M | $96M | $8M | $84M | $72M | |
| Net Change in Cash | $-22M | $52M | $-32M | $-25M | $-180M | $229M | $-1M | $-92.9K | $5M | $-38M | $17M | $7M | |
| Free Cash Flow | $-89M | $-105M | $-125M | $-217M | $-217M | $-179M | $-99M | $-76M | $-74M | $-65M | $-15M | $-31M | |
| Levered FCF | · | · | $-126M | $-218M | $-219M | $-188M | $-107M | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -132871.3% | -51616.9% | -17300.3% | -2607.3% | -16972.3% | -1674.2% | -2702.1% | -308.7% | -198.1% | -215.6% | -84.5% | -377.7% | |
| Net Margin | -130000.0% | -49254.3% | -16239.9% | -2726.7% | -17109.9% | -2245.4% | -2902.8% | -318.1% | -208.9% | -208.5% | -71.9% | -345.4% | |
| Pretax Margin | -130000.0% | -49254.3% | -16239.9% | -2705.6% | -17085.4% | -2197.9% | -2938.0% | -311.0% | -208.9% | -208.5% | -76.9% | · | |
| EBITDA Margin | -132871.3% | -51616.9% | -17300.3% | -2607.3% | -16972.3% | -1674.2% | -2702.1% | -308.7% | -198.1% | -215.6% | -84.5% | -377.7% | |
| ROA | -90.6% | -75.5% | -52.0% | -66.3% | -58.6% | -48.7% | -86.8% | -60.9% | -48.9% | -38.0% | -16.9% | -32.8% | |
| ROE | -322.8% | -151.0% | -105.8% | -114.4% | -71.2% | -71.6% | -264.2% | -84.6% | -66.4% | -49.3% | -20.3% | -44.1% | |
| ROIC | -360.3% | -164.1% | -122.7% | -120.3% | -75.4% | -26.9% | -3226.5% | -110.7% | -58.7% | -61.8% | -18.2% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 2.8 | 3.6 | 3.3 | 6.8 | 11.3 | 2.9 | 2.5 | 3.9 | 2.8 | 5.5 | 7.1 | |
| Quick Ratio | 1.3 | 2.7 | 3.4 | 2.6 | 6.2 | 10.3 | 2.8 | 2.4 | 3.8 | 2.8 | 5.4 | 6.9 | |
| Interest Coverage | · | · | -117.7 | -213.4 | -155.6 | -14.3 | -14.0 | · | · | · | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | |
| Receivables Turnover | 0.1 | 0.1 | · | 2.9 | 0.1 | 0.8 | 2.0 | 6.5 | 3.9 | 3.1 | 8.0 | 3.4 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.35 | $1.90 | $5.15 | $0.88 | $1.84 | $2.47 | $0.03 | $0.89 | $1.58 | $1.66 | $2.43 | $1.83 | |
| Revenue / Share | $0.00 | $0.01 | $0.04 | $0.04 | $0.01 | · | $0.04 | $0.33 | $0.52 | $0.48 | $0.59 | $0.18 | |
| Cash Flow / Share | $-1.89 | $-3.83 | $-5.61 | $-0.91 | $-1.03 | · | $-0.99 | $-0.79 | $-0.77 | $-0.85 | $-0.18 | $-0.50 | |
| Cash / Share | $0.64 | $1.82 | $0.63 | $0.18 | $0.33 | $1.34 | $0.22 | $0.24 | $0.26 | $0.26 | $0.80 | $0.67 | |
| EPS (TTM) | $-1.81 | $-3.95 | $-6.09 | $-14.07 | $-17.45 | $-1.07 | $-1.21 | $-1.05 | $-1.09 | $-1.01 | $-0.44 | $-0.64 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -70.0% | -73.8% | -91.9% | 478.2% | -76.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -81.5% | -50.3% | -51.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -61.2% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $65.3K | $217.8K | $832.0K | $10M | $2M | $7M | $4M | $30M | $42M | $35M | $41M | $10M | |
| Net Income TTM | $-85M | $-107M | $-135M | $-280M | $-304M | $-166M | $-119M | $-97M | $-88M | $-74M | $-29M | $-36M | |
| Market Cap | $120M | $66M | $139M | $4.74B | $13.02B | $19.84B | $4.01B | $4.67B | $4.48B | $6.17B | $5.82B | $6.69B | |
| P/E | -1.0 | -0.5 | -1.0 | -1.3 | -3.4 | -99.3 | -32.7 | -45.7 | -45.5 | -82.5 | -183.3 | -172.1 | |
| P/S | 1837.3 | 303.4 | 167.7 | 461.7 | 7334.5 | 2677.5 | 976.2 | 153.1 | 106.1 | 174.4 | 143.5 | 639.9 | |
| P/B | 5.0 | 1.0 | 1.2 | 21.3 | 32.6 | 43.0 | 1168.5 | 53.7 | 31.4 | 50.0 | 33.1 | 60.2 | |
| P / Tangible Book | 5.0 | 1.0 | 1.2 | 22.6 | 33.7 | 44.3 | · | · | · | · | · | · | |
| P / Cash Flow | -1.4 | -0.6 | -1.1 | -21.9 | -60.3 | -111.5 | -41.0 | -63.5 | -70.8 | -98.6 | -468.2 | -224.4 | |
| P / FCF | -1.4 | -0.6 | -1.1 | -21.8 | -60.0 | -110.5 | -40.6 | -61.7 | -60.9 | -94.5 | -382.6 | -214.4 | |
| Earnings Yield | -104.0% | -215.9% | -99.5% | -75.2% | -29.1% | -1.0% | -3.1% | -2.2% | -2.2% | -1.2% | -0.55% | -0.58% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $65.3K | $117.0K | $0 | $100.8K | $0 | $388.4K | $226.0K | $114.9K | $9M | $784.4K | $199.1K | |
| R&D Expense | $11M | $14M | $10M | $13M | $15M | $16M | $13M | $19M | $23M | $21M | $16M | $24M | $30M | $33M | $56M | $56M | |
| SG&A Expense | $8M | $8M | $7M | $8M | $9M | $9M | $8M | $9M | $10M | $11M | $10M | $14M | $14M | $12M | $48M | $16M | |
| Operating Expenses | $19M | $22M | $17M | $21M | $23M | $25M | $20M | $27M | $33M | $31M | $36M | $37M | $44M | $45M | $105M | $72M | |
| Operating Income | $-19M | $-22M | $-17M | $-21M | $-23M | $-25M | $-20M | $-27M | $-33M | $-31M | $-36M | $-37M | $-44M | $-36M | $-104M | $-72M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $177.8K | $313.5K | $313.5K | $313.5K | $313.5K | $313.5K | $313.5K | |
| Interest Income | $363.8K | $439.6K | $449.3K | $552.1K | $610.6K | $808.1K | $852.6K | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $857.7K | $669.8K | |
| Other Non-op | $-2M | $-285.5K | $88 | $-2M | $-703.2K | $-482 | $-2M | $-579.8K | $7.6K | $-682.2K | $2.9K | $-1M | $-2M | $-940.8K | $-3.0K | $-153.5K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-34M | $-36M | $-41M | $-38M | $-108M | $-77M | |
| Net Income | $-6M | $-20M | $4M | $-45M | $-24M | $-20M | $-19M | $-25M | $-32M | $-30M | $-34M | $-36M | $-41M | $-38M | $-108M | $-79M | |
| EPS (Basic) | $-0.07 | $-0.28 | $0.18 | $-0.87 | $-0.61 | $-0.51 | $-0.56 | $-0.89 | $-1.19 | $-1.31 | $-1.52 | $-1.61 | $-1.89 | $-0.15 | $-0.46 | $-0.36 | |
| EPS (Diluted) | $-0.07 | $-0.28 | $0.18 | $-0.87 | $-0.61 | $-0.51 | $-0.56 | $-0.89 | $-1.19 | $-1.31 | $-1.52 | $-1.61 | $-1.89 | $-0.15 | $-0.46 | $-0.36 | |
| Shares (Basic) | 81,619,113 | 69,101,910 | · | 52,168,694 | 38,830,053 | 38,613,653 | · | 28,140,497 | 27,197,802 | 23,291,512 | 22,385,229 | 22,029,486 | 21,536,476 | 249,351,023 | 235,278,276 | 218,940,693 | |
| Shares (Diluted) | 81,619,113 | 69,101,910 | · | 52,168,694 | 38,830,053 | 38,613,653 | · | 28,140,497 | 27,197,802 | 23,291,512 | 22,385,229 | 22,029,486 | 21,536,476 | 249,351,023 | 235,278,276 | 218,940,693 | |
| EBITDA | $-19M | $-22M | · | $-21M | $-23M | $-25M | · | $-27M | $-33M | $-31M | $-36M | $-37M | $-44M | $-36M | $-104M | $-72M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $26M | $44M | $37M | $24M | $40M | $66M | $22M | $34M | $20M | $19M | $53M | $28M | $22M | $41M | $59M | |
| Short-term Investments | $5M | $11M | $14M | $14M | $23M | $28M | $28M | $63M | $76M | $86M | $149M | $142M | $196M | $260M | $307M | $301M | |
| Receivables | · | · | $450 | $978.6K | $840.3K | $1M | $1M | $2M | $2M | $3M | · | · | $73.3K | $2M | $4M | $4M | |
| Prepaid Expense | $3M | $2M | $3M | $3M | $4M | $2M | $4M | $5M | $5M | $4M | $5M | $3M | $5M | $58M | $56M | $32M | |
| Current Assets | $40M | $39M | $61M | $55M | $53M | $72M | $98M | $91M | $118M | $112M | $175M | $203M | $234M | $350M | $416M | $400M | |
| PP&E (Net) | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $5M | $5M | $6M | $6M | $7M | $16M | $16M | $17M | |
| PP&E (Gross) | · | · | $20M | · | · | · | $20M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $17M | · | · | · | $16M | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | $0 | $11M | $11M | $11M | $11M | $11M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $566.4K | $585.9K | $605.3K | $605.3K | $666.9K | $652.5K | $702.0K | $770.1K | $1M | |
| Total Assets | $49M | $50M | $74M | $69M | $68M | $87M | $113M | $107M | $134M | $129M | $193M | $233M | $267M | $392M | $459M | $446M | |
| Accounts Payable | · | · | · | · | · | · | · | · | · | · | · | · | $25M | $74M | $105M | $38M | |
| Current Liabilities | $40M | $38M | $44M | $70M | $32M | $27M | $35M | $23M | $26M | $23M | $44M | $52M | $55M | $95M | $131M | $59M | |
| Capital Leases | $5M | $6M | $7M | $7M | $8M | $9M | $9M | $10M | $11M | $11M | $11M | $12M | $12M | $13M | $14M | $15M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $32.0K | $32.0K | $32.0K | $32.0K | $32.0K | $32.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | $710.3K | $0 | $0 | |
| Total Liabilities | $45M | $44M | $50M | $77M | $40M | $36M | $45M | $34M | $37M | $35M | $55M | $64M | $67M | $125M | $162M | $90M | |
| Common Stock | $82.3K | $69.8K | $69.0K | $53.6K | $36.7K | $36.7K | $36.1K | $26.1K | $26.0K | $23.4K | $269.7K | $268.1K | $262.7K | $249.5K | $247.5K | $226.5K | |
| Paid-in Capital | $1.85B | $1.84B | $1.84B | $1.81B | $1.80B | $1.80B | $1.80B | $1.78B | $1.78B | $1.75B | $1.74B | $1.73B | $1.73B | $1.70B | $1.69B | $1.64B | |
| Retained Earnings | $-1.84B | $-1.83B | $-1.82B | $-1.82B | $-1.77B | $-1.75B | $-1.73B | $-1.71B | $-1.69B | $-1.65B | $-1.60B | $-1.56B | $-1.53B | $-1.43B | $-1.40B | $-1.29B | |
| AOCI | $-280.0K | $-636.1K | $-638.0K | $-647.4K | $-661.7K | $-661.3K | $-675.7K | $-623.5K | $-689.5K | $-676.2K | $-751.1K | $-691.3K | $-582.8K | $-885.2K | $-649.7K | $-457.9K | |
| Stockholders' Equity | $4M | $6M | $24M | $-8M | $29M | $51M | $69M | $74M | $97M | $94M | $138M | $169M | $199M | $267M | $298M | $355M | |
| Liabilities + Equity | $49M | $50M | $74M | $69M | $68M | $87M | $113M | $107M | $134M | $129M | $193M | $233M | $267M | $392M | $459M | $446M | |
| Shares Outstanding | 82,341,945 | 69,773,237 | 68,996,647 | 53,571,675 | 36,718,527 | 36,674,355 | 36,099,991 | 26,052,452 | 25,963,544 | 23,371,253 | 269,731,481 | 268,073,202 | 262,739,126 | 249,485,264 | 247,504,547 | 226,510,720 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $768.4K | $698.7K | $764.6K | $757.1K | $834.8K | $1M | $1M | $1M | $2M | $3M | $2M | $3M | $4M | $3M | $8M | $8M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $63.3K | $82.1K | $120.0K | $131.0K | $126.8K | |
| Operating Cash Flow | $-18M | $-22M | $-19M | $-22M | $-21M | $-27M | $-20M | $-27M | $-28M | $-29M | $-29M | $-32M | $-37M | $-67M | $-51M | $-62M | |
| CapEx | $0 | $0 | $127.4K | $68.0K | $30.9K | $59.4K | $0 | $0 | $452.3K | $35.6K | $0 | $23.9K | $297.0K | $86.8K | $717.2K | $0 | |
| Investing Cash Flow | $6M | $3M | $-58.2K | $9M | $5M | $-51.8K | $35M | $14M | $10M | $45M | $-5M | $54M | $19M | $45M | $-10M | $21M | |
| Stock Issued | $3M | $1M | $27M | $7M | $0 | $1M | $13M | $667.1K | $17M | $5M | $708.3K | $3M | $0 | $4M | $43M | $29M | |
| Net Stock Activity | · | $1M | · | · | · | $1M | · | · | · | $5M | · | · | $0 | · | · | $29M | |
| Financing Cash Flow | $17M | $953.8K | $27M | $25M | $-34.8K | $1M | $29M | $660.6K | $33M | $-11M | $698.6K | $3M | $-424.7K | $4M | $43M | $28M | |
| Net Change in Cash | $5M | $-18M | $8M | $12M | $-16M | $-26M | $44M | $-13M | $15M | $5M | $-34M | $24M | $-18M | $-19M | $-18M | $-12M | |
| Free Cash Flow | · | $-22M | · | · | · | $-27M | · | · | · | $-29M | · | · | $-37M | · | · | $-62M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -38337.0% | · | · | -32945.9% | · | -9152.6% | -16392.0% | -38238.2% | -390.6% | -13276.1% | -36033.3% | |
| Net Margin | · | · | · | · | · | -30140.5% | · | · | -31993.3% | · | -8734.8% | -15725.3% | -35364.8% | -412.8% | -13832.0% | -39720.8% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | -8734.8% | -15725.3% | -35364.8% | -412.8% | -13832.0% | -38633.1% | |
| EBITDA Margin | · | · | · | · | · | -38337.0% | · | · | -32945.9% | · | -9152.6% | -16392.0% | -38238.2% | -390.6% | -13276.1% | -36033.3% | |
| ROA | -10.2% | -28.7% | · | -51.6% | -23.3% | -18.2% | · | -16.8% | -17.6% | -15.4% | -11.6% | -10.3% | -11.4% | -8.2% | -20.6% | -14.4% | |
| ROE | -36.5% | -68.7% | · | -138.2% | -37.5% | -27.0% | · | -23.8% | -24.2% | -20.8% | -16.8% | -15.2% | -14.7% | -10.5% | -26.9% | -16.9% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.0 | · | 0.8 | 1.7 | 2.6 | · | 3.9 | 4.5 | 4.8 | 4.0 | 3.9 | 4.2 | 3.7 | 3.2 | 6.7 | |
| Quick Ratio | 0.9 | 1.0 | · | 0.7 | 1.5 | 2.5 | · | 3.7 | 4.2 | 4.6 | 3.8 | 3.8 | 4.1 | 3.0 | 2.7 | 6.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -177.0 | -113.4 | -118.2 | -140.2 | -114.1 | -332.2 | -228.8 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | 0.1 | 2.5 | 0.1 | 0.0 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.05 | $0.09 | · | $-0.14 | $0.78 | $1.40 | · | $2.82 | $3.73 | $4.04 | $0.51 | $0.63 | $0.76 | $1.07 | $1.20 | $1.57 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | |
| Cash Flow / Share | · | $-0.31 | · | · | · | $-0.70 | · | · | · | $-1.23 | · | · | $-0.14 | · | · | $-0.28 | |
| Cash / Share | $0.38 | $0.38 | · | $0.68 | $0.66 | $1.09 | · | $0.83 | $1.32 | $0.84 | $0.07 | $0.20 | $0.11 | $0.09 | $0.17 | $0.26 | |
| EPS (TTM) | $-1.04 | $-1.58 | · | $-2.55 | $-2.57 | $-3.15 | · | · | · | · | · | · | · | $-17.47 | $-17.61 | $-17.54 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $182.3K | $182.3K | $283.1K | · | · | · | · | · | · | · | $11M | $2M | $2M | |
| Net Income TTM | $-67M | $-85M | · | $-108M | $-88M | $-96M | · | · | · | · | · | · | · | $-332M | $-355M | $-328M | |
| Market Cap | $91M | $121M | · | $125M | $75M | $60M | · | $151M | $210M | $324M | $1.26B | $1.45B | $2.59B | $5.18B | $5.14B | $9.76B | |
| P/E | -1.1 | -1.1 | · | -0.9 | -0.8 | -0.5 | · | · | · | · | · | · | · | -1.2 | -1.2 | -2.5 | |
| P/S | · | · | · | 687.5 | 410.8 | 211.2 | · | · | · | · | · | · | · | 471.8 | 2430.2 | 6088.5 | |
| P/B | 20.7 | 20.0 | · | -16.2 | 2.6 | 1.2 | · | 2.0 | 2.2 | 3.4 | 9.1 | 8.5 | 13.0 | 19.4 | 17.3 | 27.5 | |
| P / Tangible Book | 20.7 | 20.0 | · | · | 2.6 | 1.2 | · | 2.0 | 2.2 | 3.4 | 9.1 | 9.1 | 13.9 | 20.4 | 18.0 | 28.5 | |
| P / Cash Flow | · | -5.6 | · | · | · | -2.2 | · | · | · | -11.3 | · | · | -70.5 | · | · | -157.7 | |
| Earnings Yield | -94.5% | -90.8% | · | -109.0% | -126.0% | -193.2% | · | · | · | · | · | · | · | -84.2% | -84.8% | -40.7% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $65.3K | $217.8K | $832.0K | $10M | $2M |
| Margen Operativo % | -132871.3% | -51616.9% | -17300.3% | -2607.3% | -16972.3% |
| Beneficio neto | $-85M | $-107M | $-135M | $-280M | $-304M |
| EPS Diluido | $-1.81 | $-3.95 | $-6.09 | $-14.07 | $-17.45 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 1.4 | 2.8 | 3.6 | 3.3 | 6.8 |
| Ratio Rápido | 1.3 | 2.7 | 3.4 | 2.6 | 6.2 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-89M | $-105M | $-125M | $-217M | $-217M |
Propietarios institucionales (13F) 115 declarantes · $44.9M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
115
Valor en tenencia
$44.9M
Nuevas posiciones
22
Posiciones cerradas
15
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 22 (+3 vs trimestre anterior) | 15 (+2 vs trimestre anterior) | 33 (+11 vs trimestre anterior) | 16 (-10 vs trimestre anterior) | -1.4M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| FMR LLC | $9 300 277 | 8 454 797 | 20,70% | Acciones |
| JANUS HENDERSON GROUP PLC | $5 773 168 | 3 308 406 | 12,85% | Acciones |
| VANGUARD GROUP INC | $5 769 110 | 3 315 580 | 12,84% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $4 015 618 | 3 650 562 | 8,94% | Acciones |
| Boxer Capital Management, LLC | $3 129 493 | 2 844 994 | 6,96% | Acciones |
| ADAR1 Capital Management, LLC | $2 358 301 | 2 143 910 | 5,25% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 672 440 | 1 520 400 | 3,72% | Opción de compra |
| D. E. Shaw & Co., Inc. | $1 486 822 | 1 351 656 | 3,31% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $1 363 756 | 1 239 778 | 3,03% | Acciones |
| Eversept Partners, LP | $1 138 896 | 1 035 360 | 2,53% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $883 749 | 802 751 | 1,97% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $875 718 | 796 107 | 1,95% | Acciones |
| BlackRock, Inc. | $856 963 | 779 057 | 1,91% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $528 846 | 480 769 | 1,18% | Acciones |
| Caption Management, LLC | $526 845 | 478 950 | 1,17% | Acciones |
| Caption Management, LLC | $440 000 | 400 000 | 0,98% | Opción de compra |
| RENAISSANCE TECHNOLOGIES LLC | $397 473 | 361 339 | 0,88% | Acciones |
| STATE STREET CORP | $370 271 | 336 610 | 0,82% | Acciones |
| CITADEL ADVISORS LLC | $351 450 | 319 500 | 0,78% | Opción de compra |
| TUDOR INVESTMENT CORP ET AL | $330 000 | 300 000 | 0,73% | Opción de compra |
| DIADEMA PARTNERS LP | $302 720 | 275 200 | 0,67% | Opción de compra |
| UBS Group AG | $288 552 | 262 320 | 0,64% | Acciones |
| Quadrature Capital Ltd | $284 821 | 258 928 | 0,63% | Acciones |
| CITADEL ADVISORS LLC | $265 952 | 241 775 | 0,59% | Acciones |
| NORTHERN TRUST CORP | $191 833 | 174 394 | 0,43% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $190 300 | 173 000 | 0,42% | Acciones |
| NOMURA HOLDINGS INC | $165 000 | 150 000 | 0,37% | Acciones |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $147 012 | 133 648 | 0,33% | Acciones |
| GMT Capital Corp | $138 731 | 126 119 | 0,31% | Acciones |
| JANE STREET GROUP, LLC | $136 977 | 124 525 | 0,30% | Acciones |
| TWO SIGMA ADVISERS, LP | $128 240 | 73 701 | 0,29% | Acciones |
| XTX Topco Ltd | $116 416 | 105 833 | 0,26% | Acciones |
| GOLDMAN SACHS GROUP INC | $103 092 | 93 720 | 0,23% | Acciones |
| CITADEL ADVISORS LLC | $92 620 | 84 200 | 0,21% | Opción de venta |
| Invesco Ltd. | $88 372 | 80 338 | 0,20% | Acciones |
| Green Alpha Advisors, LLC | $74 861 | 68 055 | 0,17% | Acciones |
| JANE STREET GROUP, LLC | $71 940 | 65 400 | 0,16% | Opción de compra |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $63 690 | 57 900 | 0,14% | Opción de venta |
| MORGAN STANLEY | $55 283 | 50 256 | 0,12% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $46 515 | 42 286 | 0,10% | Acciones |
| Squarepoint Ops LLC | $40 030 | 36 391 | 0,09% | Acciones |
| Engineers Gate Manager LP | $37 060 | 33 691 | 0,08% | Acciones |
| Vanguard Global Advisers, LLC | $33 259 | 30 235 | 0,07% | Acciones |
| Headlands Technologies LLC | $32 878 | 29 889 | 0,07% | Acciones |
| ZACKS INVESTMENT MANAGEMENT | $29 079 | 26 435 | 0,06% | Acciones |
| Persistent Asset Partners Ltd | $22 160 | 701 | 0,05% | Opción de compra |
| Prime Capital Investment Advisors, LLC | $18 839 | 17 126 | 0,04% | Acciones |
| LPL Financial LLC | $18 826 | 17 114 | 0,04% | Acciones |
| StoneX Group Inc. | $18 077 | 14 252 | 0,04% | Acciones |
| TWO SIGMA SECURITIES, LLC | $17 554 | 15 958 | 0,04% | Acciones |
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Dr. J. Joseph Kim | 10 de junio de 2009 | · | Presentación inicial | · | SEC |
| Simon Benito, Tee Khiang Ng and Morton Collins, Voting Trustees Under Voting Trust Agreement Dated June 1, 2009 among the Issuer, the Voting Trustees and the Stockholders listed therein. | 10 de junio de 2009 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 42 insiders · 12 directivos · 24 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Jacqueline Elizabeth Shea | Chief Executive Officer | 20 de mayo de 2026 A | 111 021 | 0 | 0 | $0 |
| Jong Joseph Kim | Chief Executive Officer | 11 de marzo de 2022 M | 1 422 627 | 0 | 0 | $0 |
| Niranjan Sardesai | Chief Operating Officer | 10 de marzo de 2018 M | 123 486 | 0 | 0 | $0 |
| Michael John Sumner | Chief Medical Officer | 20 de mayo de 2026 A | 42 038 | 0 | 0 | $0 |
| Laurent Humeau | Chief Scientific Officer | 20 de mayo de 2026 A | 46 823 | 0 | 0 | $0 |
| Mark Bagarazzi | Chief Medical Officer | 5 de marzo de 2019 M | 100 672 | 0 | 0 | $0 |
| Kevin Rassas | Sr. VP Business Development | 16 de noviembre de 2009 M | 726 088 | 0 | 0 | $0 |
| Cheryl Jo White | Chief Medical Officer | 29 de junio de 2009 M | · | 0 | 0 | $0 |
| Dietmar P Rabussay | V.P. Research & Development | 8 de marzo de 2007 A | 17 386 | 0 | 0 | $0 |
| Robert S Goodenew | V.P. Corporate Development | 20 de diciembre de 2006 M | · | 0 | 0 | $0 |
| George F. Mchugh III | Vice President, Operations | 8 de marzo de 2006 A | 1 | 0 | 0 | $0 |
| Brook G Riggins | V.P. Finance & Corp. Comm. | 7 de noviembre de 2003 A | · | 0 | 0 | $0 |
| Ann Calby Miller | Consejero | 20 de mayo de 2026 A | 9 877 | 0 | 0 | $0 |
| Roger D Dansey | Consejero | 20 de mayo de 2026 A | 8 916 | 0 | 0 | $0 |
| David B. Weiner | Consejero | 20 de mayo de 2026 A | 87 592 | 0 | 0 | $0 |
| Jay Shepard | Consejero | 20 de mayo de 2026 A | 9 209 | 0 | 0 | $0 |
| Wendy L Yarno | Consejero | 20 de mayo de 2026 A | 10 512 | 0 | 0 | $0 |
| Angel Cabrera | Consejero | 8 de mayo de 2020 M | 75 602 | 0 | 0 | $0 |
| Morton Collins | Consejero | 11 de mayo de 2019 M | 168 130 | 0 | 0 | $0 |
| Avtar S Dhillon | Consejero | 6 de diciembre de 2018 M | 106 002 | 0 | 0 | $0 |
| Adel Mahmoud | Consejero | 12 de mayo de 2018 M | 22 669 | 0 | 0 | $0 |
| George Bickerstaff | Consejero | 21 de marzo de 2018 M | 4 090 | 0 | 0 | $0 |
| Nancy Wysenski | Consejero | 13 de mayo de 2016 A | 5 000 | 0 | 0 | $0 |
| Keith H Wells | Consejero | 13 de mayo de 2011 A | · | 0 | 0 | $0 |
| David J Williams | Consejero | 16 de junio de 2010 A | · | 0 | 0 | $0 |
| Chin Cheong Chong | Consejero | 9 de diciembre de 2008 A | · | 0 | 0 | $0 |
| James L Heppell | Consejero | 14 de agosto de 2008 A | 2 | 0 | 0 | $0 |
| Stephen Rietiker | Consejero | 2 de mayo de 2008 A | · | 0 | 0 | $0 |
| Robert William Rieder | Consejero | 2 de mayo de 2008 A | · | 0 | 0 | $0 |
| Riaz Amirali Bandali | Consejero | 2 de mayo de 2008 A | 2 | 0 | 0 | $0 |
| Tazdin Esmail | Consejero | 2 de mayo de 2008 A | 2 | 0 | 0 | $0 |
| Felix Theeuwes | Consejero | 7 de junio de 2006 A | 2 | 0 | 0 | $0 |
| Eugene A Larson | Consejero | 13 de mayo de 2005 A | 3 | 0 | 0 | $0 |
| Gordon Politeski | Consejero | 8 de agosto de 2003 A | · | 0 | 0 | $0 |
| MARXE AUSTIN W & GREENHOUSE DAVID M | Propietario del 10% | 3 de diciembre de 2012 S | 3 919 706 | 0 | 0 | $0 |
| Lota S. Zoth | · | 20 de mayo de 2026 A | 8 726 | 0 | 0 | $0 |
| Simon X Benito | · | 20 de mayo de 2026 A | 12 191 | 0 | 0 | $0 |
| Peter Kies | · | 20 de mayo de 2026 A | 42 854 | 0 | 0 | $0 |
| Tee Khiang Ng | · | 30 de septiembre de 2009 A | · | 0 | 0 | $0 |
| Punit Dhillon | · | 30 de septiembre de 2009 A | · | 0 | 0 | $0 |
| Michael Fons | · | 30 de septiembre de 2009 A | · | 0 | 0 | $0 |
| Beng Lee Gan | · | 2 de mayo de 2008 A | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 4 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,50% | 94 431 SH | 2 de octubre de 2026 | Diario |
| IWC · iShares Trust | 0,02% | 278 295 SH | 11 de septiembre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 963 325 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 600 092 SH | 19 de agosto de 2026 | Diario |
INO Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 8 analistas
COMPRA
Objetivo mediano
$3.00
+158,6%
2 25,0%
Compra fuerte
4 50,0%
Compra
2 25,0%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
3 analistas · 2026-09-29Objetivo medio $3.17 +173,0%
← Por Debajo de Todos los Objetivos
Precio Actual $1.16
Mín$2.50
Media$3.17
Máx$4.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| INO | $120M | -1.0 | -70.0% | -130000.0% | -322.8% | · |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
| TNYA | $154M | -1.2 | · | · | -81.2% | · |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | · |
| HURA | · | -1.2 | · | · | · | · |
| VTVT | · | · | · | · | -70.4% | · |
| CRBP | $143M | -1.4 | · | · | -60.8% | · |
| UNCY | $128M | -3.5 | -29.0% | · | -113.9% | · |
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 12, 2026